1. Home
  2. WLKP vs CERT Comparison

WLKP vs CERT Comparison

Compare WLKP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Chemical Partners LP

WLKP

Westlake Chemical Partners LP

N/A

Current Price

$22.60

Market Cap

778.9M

Sector

Industrials

ML Signal

N/A

CERT

Certara Inc.

HOLD

Current Price

$5.88

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLKP
CERT
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
778.9M
860.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
WLKP
CERT
Price
$22.60
$5.88
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$11.67
AVG Volume (30 Days)
27.1K
4.5M
Earning Date
05-01-2026
05-11-2026
Dividend Yield
8.32%
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
$1,166,695,000.00
$418,838,000.00
Revenue This Year
$19.48
$4.18
Revenue Next Year
$5.24
$5.39
P/E Ratio
$15.30
N/A
Revenue Growth
2.71
8.75
52 Week Low
$17.75
$5.19
52 Week High
$23.82
$15.38

Technical Indicators

Market Signals
Indicator
WLKP
CERT
Relative Strength Index (RSI) 53.65 44.55
Support Level $21.72 N/A
Resistance Level $22.49 $7.52
Average True Range (ATR) 0.51 0.30
MACD 0.01 0.06
Stochastic Oscillator 67.91 56.10

Price Performance

Historical Comparison
WLKP
CERT

About WLKP Westlake Chemical Partners LP

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: